Clinical Trial Update: Informing Pain Treatment Using Pharmacogenomic Analysis [NA]

View source ↗

Summary

A University of Chicago-led clinical trial is evaluating pharmacogenomic-guided pain treatment in adults receiving cancer care; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of Chicago | Conditions: Adult Patients Who Are Receiving Oncologic Care | NA | Status: RECRUITING